Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Diabetic Retinopathy

Trial Information

Evaluation of Ranibizumab in Proliferative Diabetic Retinopathy (PDR) Requiring Vitrectomy

Official Title: Evaluation of Ranibizumab on the Ease of Procedure and Complication Rate in Proliferative Diabetic Retinopathy (PDR) Requiring Vitrectomy

Summary

Evaluation of ranibizumab on the ease and procedure and complication in proliferative diabetic retinopathy (PDR) requiring vitrectomy.

Phase: Phase 3

Sponsor: Retina Associates, Kansas City

Locations (1)

Country State City Zip Facility and Contact
United States Kansas Shawnee Mission 66204 Retina Associates, PA
Lexie Manning
913-831-7400
lmanning@kcretina.com

Gregory M Fox, MD
Principal Investigator

NCT ID:NCT00516464

Date Last Changed: August 14, 2007